Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Stroke Res Treat ; 2016: 5391598, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27418997

RESUMEN

Background. Conductive Education for stroke survivors has shown promise but randomised evidence is unavailable. This study assessed the feasibility of a definitive randomised controlled trial to evaluate efficacy. Methods. Adult stroke survivors were recruited through local community notices. Those completing the baseline assessment were randomised using an online program and group allocation was independent. Intervention group participants received 10 weekly 1.5-hour sessions of Conductive Education at the National Institute of Conductive Education in Birmingham, UK. The control group participants attended two group meetings. The study evaluated the feasibility of recruitment procedures, delivery of the intervention, retention of participants, and appropriateness of outcome measures and data collection methods. Independent assessments included the Barthel Index, the Stroke Impact Scale, the Timed Up and Go test, and the Hospital Anxiety and Depression Scale. Results. Eighty-two patients were enrolled; 77 completed the baseline assessment (46 men, mean age 62.1 yrs.) and were randomised. 70 commenced the intervention (n = 37) or an equivalent waiting period (n = 33). 32/37 completed the 10-week training and 32/33 the waiting period. There were no missing items from completed questionnaires and no adverse events. Discussion. Recruitment, intervention, and assessment methods worked well. Transport issues for intervention and assessment appointments require review. Conclusion. A definitive trial is feasible. This trial is registered with ISRCTN84064492.

2.
J Biol Chem ; 280(29): 27111-20, 2005 Jul 22.
Artículo en Inglés | MEDLINE | ID: mdl-15911627

RESUMEN

Although human alanine:glyoxylate aminotransferase (AGT) is imported into peroxisomes by a Pex5p-dependent pathway, the properties of its C-terminal tripeptide (KKL) are unlike those of any other type 1 peroxisomal targeting sequence (PTS1). We have previously suggested that AGT might possess ancillary targeting information that enables its unusual PTS1 to work. In this study, we have attempted to locate this information and to determine whether or not it is a characteristic of all vertebrate AGTs. Using the two-hybrid system, we show that human AGT interacts with human Pex5p in mammalian cells, but not yeast cells. Using (immuno)fluorescence microscopic analysis of the distribution of various constructs expressed in COS cells, we show the following. 1) The putative ancillary peroxisomal targeting information (PTS1A) in human AGT is located entirely within the smaller C-terminal structural domain of 110 amino acids, with the sequence between Val-324 and Ile-345 being the most likely candidate region. 2) The PTS1A is present in all mammalian AGTs studied (human, rat, guinea pig, rabbit, and cat), but not amphibian AGT (Xenopus). 3) The PTS1A is necessary for peroxisomal import of human, rabbit, and cat AGTs, but not rat and guinea pig AGTs. We speculate that the internal PTS1A of human AGT works in concert with the C-terminal PTS1 by interacting with Pex5p indirectly with the aid of a yet-to-be-identified mammal-specific adaptor molecule. This interaction might reshape the tetratricopeptide repeat domain allosterically, enabling it to accept KKL as a functional PTS1.


Asunto(s)
Peroxisomas/metabolismo , Señales de Clasificación de Proteína , Transaminasas/metabolismo , Secuencia de Aminoácidos , Animales , Proteínas Fluorescentes Verdes , Humanos , Microscopía Fluorescente , Mutagénesis Sitio-Dirigida , Fragmentos de Péptidos/genética , Receptor de la Señal 1 de Direccionamiento al Peroxisoma , Estructura Terciaria de Proteína , Transporte de Proteínas , Receptores Citoplasmáticos y Nucleares/metabolismo , Especificidad de la Especie , Transaminasas/química , Transaminasas/genética , Transfección , Técnicas del Sistema de Dos Híbridos
3.
Exp Cell Res ; 289(2): 211-21, 2003 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-14499622

RESUMEN

Mutations in one of at least eight different genes cause bone marrow failure, chromosome instability, and predisposition to cancer associated with the rare genetic syndrome Fanconi anemia (FA). The cloning of seven genes has provided the tools to study the molecular pathway disrupted in Fanconi anemia patients. The structure of the genes and their gene products provided few clues to their functional role. We report here the use of 3 FA proteins, FANCA, FANCC, and FANCG, as "baits" in the hunt for interactors to obtain clues for FA protein functions. Using five different human cDNA libraries we screened 36.5x10(6) clones with the technique of the yeast two-hybrid system. We identified 69 proteins which have not previously been linked to the FA pathway as direct interactors of FANCA, FANCC, or FANCG. Most of these proteins are associated with four functional classes including transcription regulation (21 proteins), signaling (13 proteins), oxidative metabolism (10 proteins), and intracellular transport (11 proteins). Interaction with 6 proteins, DAXX, Ran, IkappaBgamma, USP14, and the previously reported SNX5 and FAZF, was additionally confirmed by coimmunoprecipitation and/or colocalization studies. Taken together, our data strongly support the hypothesis that FA proteins are functionally involved in several complex cellular pathways including transcription regulation, cell signaling, oxidative metabolism, and cellular transport.


Asunto(s)
Proteínas de Ciclo Celular , Proteínas de Unión al ADN/metabolismo , Anemia de Fanconi/metabolismo , Genes Reguladores/genética , Proteínas Nucleares , Fosforilación Oxidativa , Proteínas/metabolismo , Células Cultivadas , Análisis Mutacional de ADN , ADN Complementario/análisis , ADN Complementario/genética , Proteínas de Unión al ADN/genética , Escherichia coli/genética , Anemia de Fanconi/genética , Anemia de Fanconi/fisiopatología , Proteína del Grupo de Complementación A de la Anemia de Fanconi , Proteína del Grupo de Complementación C de la Anemia de Fanconi , Proteína del Grupo de Complementación G de la Anemia de Fanconi , Proteínas del Grupo de Complementación de la Anemia de Fanconi , Humanos , Transporte de Proteínas/genética , Proteínas/genética , Saccharomyces cerevisiae/genética , Transducción de Señal/genética , Técnicas del Sistema de Dos Híbridos
4.
Hum Mol Genet ; 12(19): 2503-10, 2003 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-12915460

RESUMEN

Fanconi anaemia (FA) is an autosomal recessive genetic disorder characterized by progressive bone marrow failure, multiple congenital abnormalities, and an increased risk of cancer. FA cells are characterized by chromosomal instability and hypersensitivity to DNA interstrand crosslinking agents. At least eight complementation groups exist (FA-A to G), and the genes for all of these except FA-B have been cloned. Functional linkage between the FA pathway and genes involved in susceptibility to breast cancer has been demonstrated by the interaction of the FANCA and FANCD2 proteins with BRCA1, and the discovery that the FANCD1 gene is identical to BRCA2. Here we have used the yeast two-hybrid system to test for direct interaction between BRCA2 or its effector RAD51 and the FANCA, FANCC and FANCG proteins. We found that FANCG was capable of binding to two separate sites in the BRCA2 protein, located either side of the BRC repeats. Furthermore, FANCG could be co-immunoprecipitated with BRCA2 from human cells, and FANCG co-localized in nuclear foci with both BRCA2 and RAD51 following DNA damage with mitomycin C. These results demonstrate that BRCA2 is directly connected to a pathway that is deficient in interstrand crosslink repair, and that at least one other FA protein is closely associated with the homologous recombination DNA repair machinery.


Asunto(s)
Proteína BRCA2/metabolismo , Proteínas de Ciclo Celular , Proteínas de Unión al ADN/metabolismo , Anemia de Fanconi/genética , Anemia de Fanconi/metabolismo , Proteínas Nucleares , Secuencia de Aminoácidos , Proteína BRCA2/química , Sitios de Unión , Núcleo Celular/metabolismo , Clonación Molecular , Reactivos de Enlaces Cruzados/farmacología , Daño del ADN/efectos de los fármacos , Anemia de Fanconi/patología , Proteína del Grupo de Complementación A de la Anemia de Fanconi , Proteína del Grupo de Complementación C de la Anemia de Fanconi , Proteína del Grupo de Complementación G de la Anemia de Fanconi , Proteínas del Grupo de Complementación de la Anemia de Fanconi , Regulación de la Expresión Génica , Genes Recesivos , Genes Reporteros , Vectores Genéticos , Células HeLa , Humanos , Microscopía Fluorescente , Mitomicina/farmacología , Modelos Biológicos , Pruebas de Precipitina , Proteínas/metabolismo , Recombinasa Rad51 , Técnicas del Sistema de Dos Híbridos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA